Vivo Capital, LLC Avrobio, Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$12.79 - $17.1 $2.64 Million - $3.53 Million
-206,225 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$12.99 - $19.41 $615,726 - $920,034
-47,400 Reduced 18.69%
206,225 $2.69 Million
Q2 2020

Aug 14, 2020
SELL
$12.19 - $22.96 $5.66 Million - $10.7 Million
-464,128 Reduced 64.66%
253,625 $4.43 Million
Q1 2020

May 15, 2020
BUY
$10.08 - $27.21 $7.23 Million - $19.5 Million
717,753 New
717,753 $11.2 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email